LBC Cytology with FISH Integration

Integrated platform for cancer diagnosis utilizing liquid biopsy techniques with CRISPR/Cas9 technology. Includes complete workflow from sample collection through DNA sequencing to result analysis.

Integrated diagnostic solution for cytopathology applications with automated slide scanning and digital analysis capabilities. Supports clinical cytology workflows with remote consultation features.

Advanced molecular assays for liquid biopsy applications enabling non-invasive detection of circulating biomarkers. Integrated with automated analysis for scalable clinical implementation.

Liquid biopsy diagnostic solution for non-invasive cancer monitoring and treatment personalization through cell-free DNA analysis. Automates plasma separation, DNA extraction, and quantitation to reduce pre-analytical variability and enable frequent patient monitoring for improved treatment response assessment.

Blood-based diagnostic testing methodology for non-invasive detection of genetic abnormalities and disease markers. Uses advanced sequencing techniques to analyze circulating DNA and genetic material.

A diagnostic service utilizing independently developed CTC (circulating tumor cells) and ctDNA (circulating tumor DNA) detection platforms with high sensitivity and specificity. Compared to traditional detection methods, it can identify more disease information to achieve individualized precision therapy for tumor patients. Liquid biopsy is minimally invasive and painless, providing comprehensive tumor-related information from a single blood sample, offering strong support for malignant tumor diagnosis and treatment as a complement to traditional tissue biopsy.

Liquid-based cervical cytology system for automated sample preparation and microscopic analysis. The device enables standardized processing of cervical samples with improved sample quality and diagnostic accuracy.

Precision diagnostic service utilizing liquid biopsy technology for early detection and monitoring of malignant tumors. Analyzes circulating biomarkers from patient blood samples. Enables non-invasive assessment of tumor characteristics and treatment response.

Liquid-based cytology kit combined with HPV detection for cervical cancer screening. The system integrates morphological assessment with molecular HPV testing for comprehensive cervical dysplasia evaluation.

Advanced liquid biopsy system for non-invasive detection and analysis of circulating tumor markers, circulating tumor cells, and cell-free DNA from blood samples.

Molecular diagnostic test utilizing circulating tumor DNA and biomarkers from blood samples. Enables non-invasive cancer screening and early detection. Supports monitoring of treatment response and recurrence in cancer patients.